• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Protein Expr Purif . Expression of a recombinant DIVA antigen for differential diagnosis of H7N9 subtype avian influenza virus infected and vaccinat

tetano

Editor, Senior Moderator
Protein Expr Purif


. 2026 Jul 1:242:106970.
doi: 10.1016/j.pep.2026.106970. Online ahead of print.
Expression of a recombinant DIVA antigen for differential diagnosis of H7N9 subtype avian influenza virus infected and vaccinated chickens

Wang Yu[SUP] 1 [/SUP], Jiao Hu[SUP] 2 [/SUP], Xiaoquan Wang[SUP] 2 [/SUP], Shunlin Hu[SUP] 2 [/SUP], Xiufan Liu[SUP] 3 [/SUP], Zenglei Hu[SUP] 4 [/SUP]


Affiliations
Abstract

H7N9 subtype avian influenza virus (AIV) is a great threat for poultry industry in China. Serological assays that differentiate infected and vaccinated animals (DIVA) can facilitate H7N9 virus monitoring in vaccinated poultry. A serological method based on a peptide for DIVA diagnosis of H7N9 subtype AIV was previously established. However, complex manufacturing techniques are required for production of chemically-synthesized peptides, casting the affordability and accessibility issues of such assays in poultry farms. Here, to develop an H7N9 DIVA assay suitable for poultry use, a recombinant DIVA peptide fusion protein (DPFP) was expressed in E. coli and its potential as a diagnostic antigen for H7N9 DIVA was assessed. The DPFP composed of the E. coli thioredoxin A, the H7N9 DIVA peptide and His affinity tag was efficiently expressed in a soluble form in E. coli. The DPFP was recognized by H7N9 virus infection serum rather than by H7N9 vaccination serum as determined using immunoblotting. In addition, enzyme-linked immunosorbent assay based on the DPFP was established and optimized, which can well differentiate H7N9 virus infected and vaccinated chickens. OD450 of 0.5 was defined as the cut-off value for H7N9 DIVA diagnosis. Our study indicates that prokaryotic expression system can be used as a promising platform for preparation of diagnostic antigen for discriminating H7N9 virus infected and vaccinated chickens. The method established herein can be employed as an effective and affordable approach for diagnosis and control of H7N9 avian influenza in poultry.

Keywords: Antigen; Avian influenza virus; DIVA; H7N9 subtype; Prokaryotic expression; Recombinant protein.

 
Back
Top